Login Register Cart 0
Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Histone Deacetylase (HDAC) Inhibitors: A Fruitful Lead for Medicinal Chemists in the Discovery of Novel Drug(s) for Various Health Disorders

Author(s): Dilipkumar Pal

Volume 24, Issue 9, 2023

Published on: 20 July, 2023

Page: [697 - 697] Pages: 1

DOI: 10.2174/138945012409230720102737

Price: $65

Next »
[1]
Pal D, Lal P. Tropolones and thailandepsin B as lead-like natural compounds in the development of potent and selective histone deacetylase inhibitors. Curr Drug Targets 2023; 24: 698-717.
[2]
Tiwari V, Banerjee SK. Therapeutic potential of HDAC inhibitors in the treatment of cardiac diseases: A short review. Curr Drug Targets 2023; 24: 718-27.
[3]
Pal D, Sahu P, Mishra A, Hagelgans A, Sukocheva O. Histone deacetylase inhibitors as cognitive enhancers and modifiers of mood and behavior. Curr Drug Targets 2023; 24: 728-50.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy